So, in summary, we have spent 8 years talking about a failed merger and failed license agreement, with NON-BINDING plastered over their historic pages, no Board approval, no shareholder approval, no effort whatsoever on the part of PIP to commercialize the product, apart from lawsuits, Congressional investigations, competitors suing BARDA because of SIGA, potentially 2 billion in contracts, to 400million - expectation damages too speculative to justify, promissory estoppel unjustified on appeal, to expectation damages now magically no longer too speculative to justify and PIP with a higher market cap than SIGA. Got it. I sure can pick 'em.
Not exactly, you left out that, in those 8 years, SIGA did absoutely NOTHING to diversify it's programs, develop other drugs, mitigate on the risk of it losing the case, and basically being passive in just sitting around, hoping it would win. And, with Rose's salary being about $1M/year, he's $8M richer while the rest of us are pretty much broke. I really don't ever wish bad things on people, but I really do hope he gets hit by a car and it's very painful for him.
the speculative loss of PharmAthene is reflected by the develoment of siga shares since the event based on this fair valuation, because the contract would have rewarded the risk of the development of Tecovirimat